Upcoming Webinars
Validation and Implementation of the Monocyte Activation Test as an Alternative Method to the Rabbit Pyrogen Test
Presented by Jonas Van Den Berg, Subject Matter Expert, Pyrogen Testing and Alternative Microbiological Methods at Roche, Luisa Burgmaier, Project Leader, Endotoxin and Pyrogen Testing Group at Microcoat Biotechnologie
13th May 2026
USP General Chapter <665>: Separating Fact from Fiction
Presented by Desmond G Hunt, Senior Principal Scientist at US Pharmacopeia, Dr. Samuel Kikandi, Deputy Director- Principal Engineer at Sanofi
20th May 2026
Roundtable Discussion: Sterility Testing Challenges and Opportunities for ATMPs
Presented by Dr David Roesti, PhD. Microbiology Expert/Senior Technical Steward Manufacturing Science and Technology at Novartis Pharma AG, Irving Ford, VP of Quality & Compliance at Made Scientific, Friedrich von Wintzingerode, Director, ADQC Microbiological Sciences at Roche-Genentech, Sophie Drinkwater, Associate Director in Microbiology at AstraZeneca, Brian Conti, Product & Commercial Leader at Rapid Micro Biosystems , Dr. Joseph Pierquin, Founder and CTO of Redberry, part of Lonza and Stephane Dubreux, Pharm.D. / MBA, Scientific Affairs Director for Pharma Quality Control at bioMérieux
27th May 2026
Designed for More Than Launch: Accelerating Biosimilar Manufacturing at Scale
Presented by Mark Schofield, Cytiva, Director Science
22nd June 2026
On Demand Webinars
Validating rCR on a Microfluidic Platform: A Multi-Matrix Approach
Presented by Hayden Skalski, Life Sciences Product Application Specialist at Veolia
14th April 2026
2‑Part Live Webinar Series ISO 10993 Updates in Practice: From E&L Testing Challenges to ISO 10993‑1:2025 Revisions
Presented by Elisabet Jamez, Expert Advisory Services team at Nelson Labs and Wouter Buyssens, Scientific Project Manager at Nelson Labs
31st March 2026
Regulatory Challenges of Recent Low Endotoxin Recovery Regulatory Queries: Pfizer’s Strategy to Evaluate and Implement Global Changes to Meet Evolving Expectations
Presented by Jody Peraino MS, Principal Scientist, Pfizer, Allen L. Burgenson, Global Subject Matter Expert, Testing Solutions at Lonza
20th March 2026
Considerations for mRNA-LNP Potency Assay Development for Gene Editing Products
Presented by Benjamin Hall, Associate Director in Analytical Development at Tessera Therapeutics, Gargi Chaudhuri, Ph.D., Senior Field Applications Scientist, Bio-Techne (Protein Simple)
12th March 2026
